Abstract:Aim and Objective: 4-Hydroxyphenylpyruvate dioxygenase (HPPD), converting p-hydroxyphenylpyruvate (HPPA) to homogentisate (HGA), is an important target for treating type I tyrosinemia and synthesizing novel herbicides due to its significant role in tyrosine catabolism. Hence, it is imperative to design novel HPPD inhibitors that can block HPPA-HGA conversion, which leads to the deficiency in isoprenoid redox cofactors such as plastoquinone and tocopherol, and finally caused growth inhibition. This study was undertaken to investigate structural requirements for their HPPD inhibition with better biological activity. Materials and Methods: Based on the structure-activity relationships, a series of quinolinone-2,4-diones derivatives were studied using combined of 2D multiple linear regression (2D-MLR) and 3D quantitative structure-activity relationship (3D-QSAR). Firstly, genetic algorithm (GA) was applied and descriptors generated in DRAGON 5.5 software were used for building 2D-MLR models in the QSARINGS. Then CoMFA and CoMSIA models were performed by using alignment of the common framework and the pharmacophore model. The obtained models were validated through internal and external validation to verify predictive abilities. Especially, the CoMFA and CoMSIA contour maps were used to show vital structural characteristics related to HPPD inhibitors activities. Results: The 2D-MLR liner equation and corresponding parameters were listed as follows: pK(i) = -38.2034Me+22.4078GATS2m-1.4265EEig15r-2.1849Hy+32.9158 n(tr)= 28, n(pred)=6, R-2 = 0.863, Q(2) (LOO)=0.787, Q(2) (LMO)=0.607, Q(2) (F1)=0.780, Q(2) (F2)=0.780, Q(2) (F3)=0.860, CCCpred=0.920. RMSEtr=0.253, RMSEpred=0.555, F=36.289 The steric contours graph indicated that small and negative electrostatic substitutions at R-1 and R2 regions were favorable for the better activity, and hydrogen-bond donors at this region would also increase the activity. Positive electrostatic and bulky substitutions in the R-3 position would enhance the activity. The analysis of these models suggested that the steric factor of R-4 position was crucial for activity of quinazoline-2,4-diones HPPD inhibitors, bulky substitutions might improve the bioactivity of these inhibitors greatly, meanwhile, hydrogen-bond acceptor groups in this position were required for higher activity. Conclusion: In this study, a combined 2D-MLR, CoMFA and CoMSIA models demonstrated satisfying results through internal and external validation, especially good predictive abilities and the CoMFA and CoMSIA contour maps showed vital structural characteristics related to HPPD inhibitors activities.

The synthesis of furoquinolinedione and isoxazoloquinolinedione derivatives as selective Tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitors

Synthesis and Structure-Activity Relationship of Furoquinolinediones As Inhibitors of Tyrosyl-DNA Phosphodiesterase 2 (TDP2).

Multi-Targeting Exploration of New 2-Aminothiazolyl Quinolones: Synthesis, Antimicrobial Evaluation, Interaction with Dna, Combination with Topoisomerase Iv and Penetrability into Cells

Design, Synthesis and Biological Activities of 2,3-Dihydroquinazolin-4(1h)-one Derivatives As TRPM2 Inhibitors.

Synthesis, Crystal Structures, Fluorescence and Xanthine Oxidase Inhibitory Activity of Pyrazole-Based 1,3,4-Oxadiazole Derivatives

Antitumor and Topoisomerase Ⅱα Inhibitory Activities of 3-Aryl-7-hydroxyquinolines

Exploration and Biological Evaluation of 1,3-Diamino-7h-pyrrol[3,2-f]quinazoline Derivatives As Dihydrofolate Reductase Inhibitors.

Design, synthesis and biological evaluation of 2,3-dihydro-[1,4]dioxino[2,3-f]quinazoline derivatives as EGFR inhibitors

Synthesis and Biological Evaluation of Novel Pyrimido[4,5-B]quinoline-2,4- Dione Derivatives As MDM2 Ubiquitin Ligase Inhibitors.

Development of Furo[2,3-b]quinoline Derivatives with Anti-Breast Cancer Property by Targeting Topoisomerase II.

Discovery, enantioselective synthesis of myrtucommulone E analogues as tyrosyl-DNA phosphodiesterase 2 inhibitors and their biological activities

Optimization of Cellular Activity of G9a Inhibitors 7-Aminoalkoxy-quinazolines

Exploration and Biological Evaluation of 1,3-Diamino-7 H -pyrrol[3,2- f ]quinazoline Derivatives as Dihydrofolate Reductase Inhibitors

Synthesis, Cytotoxicity and Structure-Activity Relationship of Indolizinoquinolinedione Derivatives As DNA Topoisomerase IB Catalytic Inhibitors

5-Methoxyquinoline Derivatives as a New Class of EZH2 Inhibitors.

The Oligonucleotide-Based Fluorescence Assay for the Discovery of Tyrosyl-Dna Phosphodiesterase 2 Inhibitors

Synthesis, Molecular Modeling, and Biological Evaluation of Quinazoline Derivatives Containing the 1,3,4-Oxadiazole Scaffold As Novel Inhibitors of VEGFR2

Discovery of Novel 11-Triazole Substituted Benzofuro[3,2-b]quinolone Derivatives As C-Myc G-Quadruplex Specific Stabilizers Via Click Chemistry.

Design, synthesis, and evaluation of proliferation inhibitory activity of novel L-shaped ortho-quinone analogs as anticancer agents

New Research for Quinazoline-2,4-diones as HPPD Inhibitors Based on 2D-MLR and 3D-QSAR Models.

New Quinazoline Derivatives for Telomeric G-Quadruplex Dna: Effects of an Added Phenyl Group on Quadruplex Binding Ability